Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H16O4S2 |
Molecular Weight | 288.383 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1
InChI
InChIKey=YPIQVCUJEKAZCP-UHFFFAOYSA-N
InChI=1S/C12H16O4S2/c1-7(2)15-10(13)9(11(14)16-8(3)4)12-17-5-6-18-12/h5-8H,1-4H3
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/2544209Curator's Comment: description was created based on several sources, including
https://www.medchemexpress.com/malotilate.html
Sources: http://www.ncbi.nlm.nih.gov/pubmed/2544209
Curator's Comment: description was created based on several sources, including
https://www.medchemexpress.com/malotilate.html
Malotilate (NKK-105) is a drug used in the treatment of liver disease. Malotilate selectively inhibits the 5-lipoxygenase. Malotilate prevented increases in serum markers of type III and IV collagen synthesis as well as accumulation of the collagens, laminin and fibronectin in the liver.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL215 Sources: http://www.ncbi.nlm.nih.gov/pubmed/2537738 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/3743616
Six patients in an open 6-month trial received malotilate 200 mg t.i.d. for 2 months and 400 mg t.i.d. for 4 months
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/7097806
Effects of NKK-105 (MALOTILATE) against lipid peroxidation of microsomes by CCl4 are investigated, in vitro. NKK-105 had no effect on microsomal lipid peroxidation. With the microsomal fraction was preincubated with NKK-105 before adding CCl4, the lipid peroxidation induced with CCl4 was almost prevented by NKK-105.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000081740
Created by
admin on Fri Dec 15 17:52:53 GMT 2023 , Edited by admin on Fri Dec 15 17:52:53 GMT 2023
|
PRIMARY | |||
|
261-987-3
Created by
admin on Fri Dec 15 17:52:53 GMT 2023 , Edited by admin on Fri Dec 15 17:52:53 GMT 2023
|
PRIMARY | |||
|
m7046
Created by
admin on Fri Dec 15 17:52:53 GMT 2023 , Edited by admin on Fri Dec 15 17:52:53 GMT 2023
|
PRIMARY | Merck Index | ||
|
1627
Created by
admin on Fri Dec 15 17:52:53 GMT 2023 , Edited by admin on Fri Dec 15 17:52:53 GMT 2023
|
PRIMARY | |||
|
59937-28-9
Created by
admin on Fri Dec 15 17:52:53 GMT 2023 , Edited by admin on Fri Dec 15 17:52:53 GMT 2023
|
PRIMARY | |||
|
MALOTILATE
Created by
admin on Fri Dec 15 17:52:53 GMT 2023 , Edited by admin on Fri Dec 15 17:52:53 GMT 2023
|
PRIMARY | |||
|
CHEMBL1697754
Created by
admin on Fri Dec 15 17:52:53 GMT 2023 , Edited by admin on Fri Dec 15 17:52:53 GMT 2023
|
PRIMARY | |||
|
C170147
Created by
admin on Fri Dec 15 17:52:53 GMT 2023 , Edited by admin on Fri Dec 15 17:52:53 GMT 2023
|
PRIMARY | |||
|
RV59PND975
Created by
admin on Fri Dec 15 17:52:53 GMT 2023 , Edited by admin on Fri Dec 15 17:52:53 GMT 2023
|
PRIMARY | |||
|
AA-2
Created by
admin on Fri Dec 15 17:52:53 GMT 2023 , Edited by admin on Fri Dec 15 17:52:53 GMT 2023
|
PRIMARY | |||
|
SUB08640MIG
Created by
admin on Fri Dec 15 17:52:53 GMT 2023 , Edited by admin on Fri Dec 15 17:52:53 GMT 2023
|
PRIMARY | |||
|
4006
Created by
admin on Fri Dec 15 17:52:53 GMT 2023 , Edited by admin on Fri Dec 15 17:52:53 GMT 2023
|
PRIMARY | |||
|
DTXSID7046463
Created by
admin on Fri Dec 15 17:52:53 GMT 2023 , Edited by admin on Fri Dec 15 17:52:53 GMT 2023
|
PRIMARY | |||
|
4944
Created by
admin on Fri Dec 15 17:52:53 GMT 2023 , Edited by admin on Fri Dec 15 17:52:53 GMT 2023
|
PRIMARY |
ACTIVE MOIETY